Carol Giltner Gallagher - Net Worth and Insider Trading
Carol Giltner Gallagher Net Worth
The estimated net worth of Carol Giltner Gallagher is at least $207,844 dollars as of 2024-11-10. Carol Giltner Gallagher is the Director of Atara Biotherapeutics Inc and owns about 18,377 shares of Atara Biotherapeutics Inc (ATRA) stock worth over $207,844. Details can be seen in Carol Giltner Gallagher's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carol Giltner Gallagher has not made any transactions after 2023-11-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carol Giltner Gallagher
Carol Giltner Gallagher Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carol Giltner Gallagher owns 12 companies in total, including Metacrine Inc (MTCR) , Annexon Inc (ANNX) , and Millendo Therapeutics Inc (MLND) among others .
Click here to see the complete history of Carol Giltner Gallagher’s form 4 insider trades.
Insider Ownership Summary of Carol Giltner Gallagher
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MTCR | Metacrine Inc | 2020-09-15 | director |
ANNX | Annexon Inc | 2020-07-23 | director |
MLND | Millendo Therapeutics Inc | 2020-06-22 | director |
2023-11-14 | director | ||
2019-07-24 | director | ||
2017-01-25 | director | ||
2018-12-07 | director | ||
2021-06-15 | director | ||
2022-11-22 | director | ||
2022-11-22 | director | ||
2022-11-03 | director | ||
2023-06-22 | director |
Carol Giltner Gallagher Latest Holdings Summary
Carol Giltner Gallagher currently owns a total of 1 stock. Carol Giltner Gallagher owns 18,377 shares of Atara Biotherapeutics Inc (ATRA) as of November 14, 2023, with a value of $207,844.
Latest Holdings of Carol Giltner Gallagher
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ATRA | Atara Biotherapeutics Inc | 2023-11-14 | 18,377 | 11.31 | 207,844 |
Holding Weightings of Carol Giltner Gallagher
Carol Giltner Gallagher Form 4 Trading Tracker
According to the SEC Form 4 filings, Carol Giltner Gallagher has made a total of 1 transactions in Atara Biotherapeutics Inc (ATRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Atara Biotherapeutics Inc is the acquisition of 10,800 shares on November 14, 2023, which cost Carol Giltner Gallagher around $67,500.
Insider Trading History of Carol Giltner Gallagher
- 1
Carol Giltner Gallagher Trading Performance
GuruFocus tracks the stock performance after each of Carol Giltner Gallagher's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carol Giltner Gallagher is 121.45%. GuruFocus also compares Carol Giltner Gallagher's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carol Giltner Gallagher within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Carol Giltner Gallagher's insider trading performs compared to the benchmark.
Performance of Carol Giltner Gallagher
Carol Giltner Gallagher Ownership Network
Ownership Network List of Carol Giltner Gallagher
Ownership Network Relation of Carol Giltner Gallagher
Carol Giltner Gallagher Owned Company Details
What does Metacrine Inc do?
Who are the key executives at Metacrine Inc?
Carol Giltner Gallagher is the director of Metacrine Inc. Other key executives at Metacrine Inc include Chief Business Officer Michael York , director & President & CEO Preston Klassen , and 10 percent owner Braden Michael Leonard .
Metacrine Inc (MTCR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metacrine Inc (MTCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Metacrine Inc Insider Transactions
Carol Giltner Gallagher Mailing Address
Above is the net worth, insider trading, and ownership report for Carol Giltner Gallagher. You might contact Carol Giltner Gallagher via mailing address: C/o Atara Biotherapeutics, Inc., 3260 Bayshore Boulevard, Brisbane Ca 94005.